Farglitazar

Farglitazar
Systematic (IUPAC) name
N-(o-benzoylphenyl)-O-[2-(5-methyl- 2-phenyl-4-oxazolyl)ethyl]-L-tyrosine
Clinical data
Pregnancy
category
  • N/A
Legal status
  • Investigational
Identifiers
CAS Number 196808-45-4 N
ATC code None
PubChem CID 170364
IUPHAR/BPS 2672
ChemSpider 148961 N
UNII 3433GY7132 YesY
ChEMBL CHEMBL107367 N
Chemical data
Formula C34H30N2O5
Molar mass 546.612 g/mol
 NYesY (what is this?)  (verify)

Farglitazar is a peroxisome proliferator-activated receptor agonist which is being developed by GlaxoSmithKline for the treatment of hepatic fibrosis. It is currently in phase II clinical trials.

References



    This article is issued from Wikipedia - version of the Sunday, August 23, 2015. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.